Today: 6 June 2026

Leokadia Głogulska

Veeva Shares Drop Despite Earnings Beat, Investors Eye AI Move

Veeva Shares Drop Despite Earnings Beat, Investors Eye AI Move

Veeva shares slid 2.3% to $178.69 and dropped further after hours despite beating Q1 estimates and raising 2027 guidance, as investors weighed AI spending and CRM migration risks; management highlighted rapid AI progress and Vault CRM growth, but warned customer transitions could cause disruption, with Salesforce winning commitments from some large clients.
Partners Group Drops 17% After Cap on $8.6 Billion Fund Outflows

Partners Group Drops 17% After Cap on $8.6 Billion Fund Outflows

Partners Group shares plunged 16% to CHF 687.30 after capping withdrawals from its $8.6 billion Global Value SICAV fund, as redemption requests hit 9.8% of net asset value, nearly double the 5% quarterly limit; the move triggered sharp declines in peers EQT, CVC, and Bridgepoint, and marked the worst day on record for Partners Group shares, now down about 30% for the year.
3 June 2026
Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Inc. shares slid 1.5% to $5.76 Tuesday—about 45% below last July’s high—even as the broader market rose, spotlighting investor doubts about Snap’s turnaround despite first-quarter revenue growth, narrowed losses, and major cost cuts; ad growth remains sluggish and the upcoming Specs update on June 16 is seen as a key test for future revenue momentum.
Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch

Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch

Bluejay Diagnostics shares soared 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, as investors bet on the company’s move from clinical development to commercialization; however, the stock remains risky with ongoing capital needs, pending FDA clearance, and reliance on successful clinical and manufacturing milestones.
2 June 2026

Stock Market Today

  • Corebridge Financial (CRBG) Valuation Review Amid Recent Price Fluctuations
    June 6, 2026, 11:10 AM EDT. Corebridge Financial's (CRBG) stock has gained 1.7% in the past day but dropped 4.2% over the last month, trading at $26.86. The company shows mixed momentum with a 5.96% return over 90 days but an 11.56% decline year-to-date. Analysts place its fair value at $35.08, suggesting it is about 23.4% undervalued based on long-term earnings projections and a discount rate of 8.74%. Investments in AI and digital modernization have improved margins and reduced expenses. However, the stock's price-to-earnings ratio of 50.1 times is significantly higher than industry and peer averages, indicating a rich valuation that could amplify risks if growth assumptions falter. Investors should weigh potential mispricing against risks tied to future interest rate trends and partnership stability.

Latest articles

Altria Stock Outperformed in a Rough Week, With DC Still in Focus

Altria Stock Outperformed in a Rough Week, With DC Still in Focus

6 June 2026
Altria surged 2.25% to $72.19 Friday—defying a 2.6% S&P 500 drop—as investors weighed Senate scrutiny over FDA vape policy and a looming June 15 dividend cutoff; the stock gained 3.8% for the week, sits 3% below its 52-week high, and reaffirmed 2026 EPS guidance of $5.56–$5.72.
General Mills Stock Rises as Market Slips, But Gains Look Shaky

General Mills Stock Rises as Market Slips, But Gains Look Shaky

6 June 2026
General Mills (GIS.N) jumped 2.95% to $33.15 Friday as investors sought defensive stocks during a U.S. selloff, but the stock remains about 2% below last week’s close, with analysts’ average price target at $31 signaling downside risk amid weak sales and earnings; investors await July 1 results for signs of real recovery.
Berkshire Hathaway Shares Up After Greg Abel Makes $16.8 Billion Move

Berkshire Hathaway Shares Up After Greg Abel Makes $16.8 Billion Move

6 June 2026
Berkshire Hathaway’s Class B shares jumped 1.98% to $488.13 after announcing $16.8 billion in deals—including the $6.8 billion Taylor Morrison buyout and a $10 billion private placement in Alphabet—even as the S&P 500 and Nasdaq plunged, marking CEO Greg Abel’s first major capital-allocation moves and shifting Berkshire from a cash-hoard to a deployment story.
Enphase Drops 18% Ahead of Market Open

Enphase Drops 18% Ahead of Market Open

6 June 2026
Enphase Energy plunged 18% to $56.07 Friday, underperforming solar peers as U.S. jobs data sent bond yields higher and revived interest rate fears; the stock ended the week 12% below Monday’s close, with Q1 revenue down 18% and U.S. demand off 48% from last quarter, putting Monday’s open in sharp focus for investors.
Go toTop